Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Mankind Pharma
NSEI:MANKIND Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Mankind Pharma
Popular
Undervalued
Overvalued
Mankind Pharma
WA
Analyst Price Target
Consensus Narrative from 16 Analysts
Integration Of BSV Will Diversify Portfolio And Open Niche Markets
Key Takeaways Strategic partnerships and diversification into niche markets are anticipated to drive revenue and margin growth through high entry barrier portfolios. Efficiency enhancements and financial management may boost margin improvements and earnings through productivity gains and reduced finance costs.
View narrative
₹2.82k
FV
18.9% undervalued
intrinsic discount
18.29%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
about 1 month ago
author updated this narrative
Your Valuation for
MANKIND
Mankind Pharma
Your Fair Value
₹
Current Price
₹2.29k
16.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
256b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹255.9b
Earnings ₹44.9b
Advanced
Set as Fair Value